Literature DB >> 28114818

Functional Screening Identifies Human miRNAs that Modulate Adenovirus Propagation in Prostate Cancer Cells.

Jasmina Hodzic1, Daoud Sie2, Annaleen Vermeulen3, Victor W van Beusechem1.   

Abstract

Oncolytic adenoviruses represent a novel class of anticancer agents. Their efficacy in killing cancer cells is variable, suggesting that there is room for improvement. Host miRNAs have been shown to play important roles in susceptibility of cells to replication of different viruses. This study investigated if adenovirus replication in human prostate cancer cells is influenced by host cell miRNA expression. To this end, human miRNA expression in response to adenovirus infection was analyzed, and functional screens for lytic adenovirus replication were performed using synthetic miRNA mimic and inhibitor libraries. Adenovirus infection generally reduced miRNA expression. On top of this nonspecific interference with miRNA biogenesis, a set of miRNAs, including in particular miR-222, was found specifically reduced. Another set of miRNAs was found to promote adenovirus-induced death of prostate cancer cells. In most cases, this did not stimulate adenovirus propagation. The exception was miR-26b. Overexpression of miR-26b inhibited adenovirus-induced NF-κB activation, augmented adenovirus-mediated cell death, increased adenovirus progeny release, and promoted adenovirus propagation and spread in several human prostate cancer cell lines. This suggests that miR-26b is particularly useful to be combined with oncolytic adenovirus for more effective treatment of prostate cancer.

Entities:  

Keywords:  miR-26; microRNA; oncolytic adenovirus; prostate cancer; virus-host interaction

Mesh:

Substances:

Year:  2017        PMID: 28114818     DOI: 10.1089/hum.2016.143

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  10 in total

Review 1.  Potentiating prostate cancer immunotherapy with oncolytic viruses.

Authors:  Patrick Lee; Shashi Gujar
Journal:  Nat Rev Urol       Date:  2018-02-13       Impact factor: 14.432

2.  Functional Screen for microRNAs Suppressing Anchorage-Independent Growth in Human Cervical Cancer Cells.

Authors:  Angelina Huseinovic; Annelieke Jaspers; Annina P van Splunter; Hanne Sørgård; Saskia M Wilting; Dorian R A Swarts; Ida H van der Meulen; Victor W van Beusechem; Renée X de Menezes; Renske D M Steenbergen
Journal:  Int J Mol Sci       Date:  2022-04-26       Impact factor: 6.208

Review 3.  MicroRNA.

Authors:  Thomas X Lu; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2017-10-23       Impact factor: 10.793

4.  Bioselection Reveals miR-99b and miR-485 as Enhancers of Adenoviral Oncolysis in Pancreatic Cancer.

Authors:  Maria Rovira-Rigau; Giulia Raimondi; Miguel Ángel Marín; Meritxell Gironella; Ramon Alemany; Cristina Fillat
Journal:  Mol Ther       Date:  2018-09-27       Impact factor: 11.454

5.  Spatial and temporal proteome dynamics of glioma cells during oncolytic adenovirus Delta-24-RGD infection.

Authors:  Andrea González-Morales; Aintzane Zabaleta; Elizabeth Guruceaga; Marta M Alonso; Marc García-Moure; Joaquín Fernández-Irigoyen; Enrique Santamaría
Journal:  Oncotarget       Date:  2018-07-24

Review 6.  Crucial Roles of microRNA-Mediated Autophagy in Urologic Malignancies.

Authors:  Maolei Shen; Xin Li; Biao Qian; Qiang Wang; Shanan Lin; Wenhao Wu; Shuai Zhu; Rui Zhu; Shankun Zhao
Journal:  Int J Biol Sci       Date:  2021-07-31       Impact factor: 6.580

Review 7.  Win or loss? Combination therapy does improve the oncolytic virus therapy to pancreatic cancer.

Authors:  Wenhao Luo; Yawen Wang; Taiping Zhang
Journal:  Cancer Cell Int       Date:  2022-04-20       Impact factor: 6.429

8.  Differential microRNA Expression in Newcastle Disease Virus-Infected HeLa Cells and Its Role in Regulating Virus Replication.

Authors:  Yu Chen; Shanshan Zhu; Yuru Pei; Jiao Hu; Zenglei Hu; Xiaowen Liu; Xiaoquan Wang; Min Gu; Shunlin Hu; Xiufan Liu
Journal:  Front Oncol       Date:  2021-06-04       Impact factor: 6.244

Review 9.  MicroRNAs as Important Players in Host-Adenovirus Interactions.

Authors:  Diogo Piedade; José M Azevedo-Pereira
Journal:  Front Microbiol       Date:  2017-07-17       Impact factor: 5.640

Review 10.  Implications of MicroRNAs in Oncolytic Virotherapy.

Authors:  Xavier Bofill-De Ros; Maria Rovira-Rigau; Cristina Fillat
Journal:  Front Oncol       Date:  2017-07-04       Impact factor: 6.244

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.